دورية أكاديمية

PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.

التفاصيل البيبلوغرافية
العنوان: PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.
المؤلفون: Schmidt CM; Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. maxschmi@iupui.edu, Yip-Schneider MT, Ralstin MC, Wentz S, DeWitt J, Sherman S, Howard TJ, McHenry L, Dutkevitch S, Goggins M, Nakeeb A, Lillemoe KD
المصدر: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2008 Feb; Vol. 12 (2), pp. 243-9. Date of Electronic Publication: 2007 Nov 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: United States NLM ID: 9706084 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1091-255X (Print) Linking ISSN: 1091255X NLM ISO Abbreviation: J Gastrointest Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 2024-: [Amsterdam] : Elsevier B.V.
Original Publication: St. Louis, MO : Quality Medical Pub., c1997-
مواضيع طبية MeSH: Carcinoma, Pancreatic Ductal/*diagnosis , Carcinoma, Pancreatic Ductal/*metabolism , Carcinoma, Papillary/*diagnosis , Carcinoma, Papillary/*metabolism , Dinoprostone/*metabolism , Pancreatic Cyst/*metabolism , Pancreatic Neoplasms/*diagnosis , Pancreatic Neoplasms/*metabolism, Adenocarcinoma/diagnosis ; Adenocarcinoma/metabolism ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Papillary/pathology ; Diagnosis, Differential ; Enzyme-Linked Immunosorbent Assay ; Humans
مستخلص: Current management of intraductal papillary mucinous neoplasm (IPMN) according to recently published International Consensus Guidelines depends upon distinguishing it from mucinous cystic neoplasms (MCNs). We have previously shown that prostaglandin E(2) (PGE(2)) is increased in pancreatic cancer tissue over normal controls. Thus, we hypothesized that PGE(2) level in pancreatic fluid differentiates IPMN and MCN and is a biomarker of IPMN dysplasia. Pancreatic fluid was collected in 65 patients at the time of endoscopy (EUS or ERCP) or operation (OR) and analyzed by PGE(2) enzyme-linked immunosorbent assay (ELISA). PGE(2) level was correlated with surgical pathologic diagnosis and dysplastic stage. Mean PGE(2) level (pg/microl) in IPMNs (2.2 +/- 0.6) was greater than in MCNs (0.2 +/- 0.1) (p < 0.05). Mean PGE(2) level of IPMN by dysplastic stage was 0.1 +/- 0.01 (low grade), 1.2 +/- 0.6 (medium grade), 4.4 +/- 0.9 (high grade), and 5.0 +/- 2.3 (invasive). Among invasive IPMN, PGE(2) level dropped in advanced cases with pancreatic ductal obstruction by tumor (0.3 +/- 0) vs non-obstructed (8.6 +/- 2.9). PGE(2) level may help in distinguishing IPMN from MCN in patients with known mucinous lesions. PGE(2) level may also be an indicator of malignant progression of IPMN before ductal obstruction by tumor. Prospective evaluation will be necessary to evaluate the clinical role of PGE(2) level in pancreatic fluid.
References: Ann Surg. 2004 Mar;239(3):400-8. (PMID: 15075659)
Gastroenterology. 2002 Nov;123(5):1500-7. (PMID: 12404225)
J Surg Oncol. 2006 Aug 1;94(2):91-3. (PMID: 16847916)
Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9. (PMID: 15166958)
Neoplasia. 2006 Jun;8(6):437-45. (PMID: 16820089)
Pancreatology. 2006;6(1-2):17-32. (PMID: 16327281)
Arch Surg. 2003 Jun;138(6):610-7; discussion 617-8. (PMID: 12799331)
Ann Surg. 2001 Sep;234(3):313-21; discussion 321-2. (PMID: 11524584)
Ann Surg. 2004 May;239(5):651-7; discussion 657-9. (PMID: 15082969)
Ann Surg. 2004 May;239(5):678-85; discussion 685-7. (PMID: 15082972)
معلومات مُعتمدة: 1 R03 CA 112629-01A1 United States CA NCI NIH HHS
المشرفين على المادة: K7Q1JQR04M (Dinoprostone)
تواريخ الأحداث: Date Created: 20071121 Date Completed: 20080724 Latest Revision: 20240213
رمز التحديث: 20240213
DOI: 10.1007/s11605-007-0404-8
PMID: 18027059
قاعدة البيانات: MEDLINE
الوصف
تدمد:1091-255X
DOI:10.1007/s11605-007-0404-8